DK165919C - N-substituerede 3-piperidin- eller 3-pyridincarboxylsyrederivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende forbindelserne - Google Patents

N-substituerede 3-piperidin- eller 3-pyridincarboxylsyrederivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende forbindelserne

Info

Publication number
DK165919C
DK165919C DK528086A DK528086A DK165919C DK 165919 C DK165919 C DK 165919C DK 528086 A DK528086 A DK 528086A DK 528086 A DK528086 A DK 528086A DK 165919 C DK165919 C DK 165919C
Authority
DK
Denmark
Prior art keywords
compounds
piperidine
procedures
substituted
preparing
Prior art date
Application number
DK528086A
Other languages
Danish (da)
English (en)
Other versions
DK528086A (da
DK165919B (da
DK528086D0 (da
Inventor
Michael R Pavia
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK528086D0 publication Critical patent/DK528086D0/da
Publication of DK528086A publication Critical patent/DK528086A/da
Publication of DK165919B publication Critical patent/DK165919B/da
Application granted granted Critical
Publication of DK165919C publication Critical patent/DK165919C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK528086A 1985-11-08 1986-11-05 N-substituerede 3-piperidin- eller 3-pyridincarboxylsyrederivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende forbindelserne DK165919C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US79634585A 1985-11-08 1985-11-08
US79634585 1985-11-08
US89730886A 1986-08-21 1986-08-21
US89730886 1986-08-21

Publications (4)

Publication Number Publication Date
DK528086D0 DK528086D0 (da) 1986-11-05
DK528086A DK528086A (da) 1987-05-09
DK165919B DK165919B (da) 1993-02-08
DK165919C true DK165919C (da) 1993-06-28

Family

ID=27121724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK528086A DK165919C (da) 1985-11-08 1986-11-05 N-substituerede 3-piperidin- eller 3-pyridincarboxylsyrederivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende forbindelserne

Country Status (15)

Country Link
EP (1) EP0221572B1 (fr)
KR (1) KR900005023B1 (fr)
CN (1) CN86107695A (fr)
AT (1) ATE67756T1 (fr)
AU (1) AU590172B2 (fr)
CA (1) CA1270818A (fr)
DE (1) DE3681690D1 (fr)
DK (1) DK165919C (fr)
ES (1) ES2040201T3 (fr)
FI (1) FI864246A7 (fr)
GR (1) GR3002842T3 (fr)
NO (1) NO864443L (fr)
NZ (1) NZ218170A (fr)
PH (1) PH24683A (fr)
PT (1) PT83705B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer
DK74593D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
IL112223A0 (en) * 1994-01-04 1995-03-30 Novo Nordisk As Pharmaceutical compositions for the treatment of neurological inflammatory conditions
AU5271896A (en) * 1995-04-07 1996-10-23 Novo Nordisk A/S Novel heterocyclic compounds
WO1996031468A1 (fr) * 1995-04-07 1996-10-10 Novo Nordisk A/S Nouveaux composes heterocycliques
EP0820442A1 (fr) * 1995-04-07 1998-01-28 Novo Nordisk A/S Nouveaux composes heterocycliques
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
JPH11503130A (ja) * 1995-04-07 1999-03-23 ノボ ノルディスク アクティーゼルスカブ 新規方法
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
HRP20030696A2 (en) 2001-02-16 2005-04-30 NPS Allelix Corp. Allelix Neuroscience GlyT-1 INHIBITORS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) * 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters

Also Published As

Publication number Publication date
FI864246A7 (fi) 1987-05-09
PT83705B (pt) 1989-05-12
AU6481286A (en) 1987-05-14
EP0221572B1 (fr) 1991-09-25
FI864246A0 (fi) 1986-10-20
DE3681690D1 (de) 1991-10-31
DK528086A (da) 1987-05-09
PT83705A (en) 1986-12-01
KR870004955A (ko) 1987-06-02
ES2040201T3 (es) 1993-10-16
KR900005023B1 (ko) 1990-07-18
NO864443L (no) 1987-05-11
NO864443D0 (no) 1986-11-07
GR3002842T3 (en) 1993-01-25
CA1270818A (fr) 1990-06-26
AU590172B2 (en) 1989-10-26
PH24683A (en) 1990-09-07
EP0221572A3 (en) 1987-07-29
NZ218170A (en) 1990-07-26
ATE67756T1 (de) 1991-10-15
DK165919B (da) 1993-02-08
DK528086D0 (da) 1986-11-05
EP0221572A2 (fr) 1987-05-13
CN86107695A (zh) 1987-05-13

Similar Documents

Publication Publication Date Title
DK165919C (da) N-substituerede 3-piperidin- eller 3-pyridincarboxylsyrederivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende forbindelserne
ATE117553T1 (de) Substituierte dihydroisochinolinone und verwandte verbindungen als verstärker der letalen effekte von bestrahlung und bestimmten chemotherapeutika; ausgewählte verbindungen, analoga und verfahren.
LU88317I2 (fr) Chlorhydrate d'esmolol (Brevibloc)
ES2038613T3 (es) Procedimiento para preparar derivados de 4,5,6,7-tetrahidro-1h-imidazo(4,5-c)piridina y analogos de los mismos que tienen actividad antihipertensiva.
NZ225758A (en) Substituted amine derivatives; pharmaceutical compositions and processes for preparation
DE3867736D1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
DK0900200T3 (da) Farmaceutiske sammensætninger til forebyggelse og behandling af sygdom i centralnervesystemet
PT88577A (pt) Process for the manufacture of novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
IL192287A0 (en) Pharmaceutical compositions and methods for use
ES2068194T3 (es) Alfa-aminoacidos substituidos que tienen actividad farmaceutica.
EP0346927A3 (fr) Acides 3-pipéridine-carboxyliques N-substitués ou acides 3-pyridine-carboxyliques N-substitués et leurs dérivés
PT83045B (pt) Processo para a obtencao de derivados aminoalcoois peptidicos contendo um atomo de carbono tetrasubstituido inibidores da renina e das proteases acidas
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
FI871304A0 (fi) Menetelmä nootrooppisen vaikutuksen omaavien aminohappojohdannaisten valmistamiseksi
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
NO164021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktiv (r,s)-5-amino-hepta-5,6-diensyre, (s)-4-aminohepta-5,6-diensyre og farmasoeytisk akseptable salter derav.
DK166384C (da) Analogifremgangsmaade til fremstilling af (-)-15-deoxyspergualing og farmaceutisk acceptable syreadditionsssalte heraf samt mellemprodukt
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound

Legal Events

Date Code Title Description
PBP Patent lapsed